New CEO at CMP Therapeutics
This article was originally published in Scrip
Executive Summary
CMP Therapeutics (UK) has appointed Dr Neill Moray Mackenzie chief executive officer. He succeeds Dr Bruce Savage, who is leaving the company. Dr Mackenzie has management experience in the pharmaceutical and biotech industries, having most recently served as senior vice-president for business development and corporate strategy at Medigene and as CEO of Roji.